Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PIALOUX

Showing results (391-400 of 578) with videos related to

Pageof 58
Sort By:
Journal of Virology|January 22, 2000
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccineH Gahéry-Ségard, G Pialoux, B Charmeteau, et al.
AIDS (London, England)|March 2, 2002
Final analysis of the Trilège induction-maintenance trial: results at 18 monthsPhilippe Flandre, François Raffi, Diane Descamps, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancyJ B Pain, M P Lê, M Caseris, et al.
AIDS (London, England)|June 27, 2001
Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteersG Pialoux, H Gahéry-Ségard, S Sermet, et al.
AIDS (London, England)|August 2, 2003
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)Eric Rosenthal, Marilyne Poirée, Christian Pradier, et al.
Biomedicines|August 26, 2022
Investigation of Blood Coagulation Using Impedance Spectroscopy: Toward Innovative Biomarkers to Assess Fibrinogenesis and Clot RetractionGiulia D'Ambrogio, Omar Zahhaf, Minh-Quyen Le, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2009
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 studyRoland Landman, Catherine Capitant, Diane Descamps, et al.
Journal De Mycologie Medicale|May 2, 2013
[Comment on this case report]G Belkadi, G Buot, Y Senghor, et al.
AIDS Research and Human Retroviruses|December 28, 2012
High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapyPascale Leclercq, Cecile Goujard, Martin Duracinsky, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2008
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004C Larsen, G Pialoux, D Salmon, et al.
Pageof 58

Showing results (391-400 of 578) with videos related to

Sort By:
Pageof 58
Journal of Virology|January 22, 2000
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccineH Gahéry-Ségard, G Pialoux, B Charmeteau, et al.
AIDS (London, England)|March 2, 2002
Final analysis of the Trilège induction-maintenance trial: results at 18 monthsPhilippe Flandre, François Raffi, Diane Descamps, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancyJ B Pain, M P Lê, M Caseris, et al.
AIDS (London, England)|June 27, 2001
Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteersG Pialoux, H Gahéry-Ségard, S Sermet, et al.
AIDS (London, England)|August 2, 2003
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)Eric Rosenthal, Marilyne Poirée, Christian Pradier, et al.
Biomedicines|August 26, 2022
Investigation of Blood Coagulation Using Impedance Spectroscopy: Toward Innovative Biomarkers to Assess Fibrinogenesis and Clot RetractionGiulia D'Ambrogio, Omar Zahhaf, Minh-Quyen Le, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2009
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 studyRoland Landman, Catherine Capitant, Diane Descamps, et al.
Journal De Mycologie Medicale|May 2, 2013
[Comment on this case report]G Belkadi, G Buot, Y Senghor, et al.
AIDS Research and Human Retroviruses|December 28, 2012
High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapyPascale Leclercq, Cecile Goujard, Martin Duracinsky, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2008
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004C Larsen, G Pialoux, D Salmon, et al.
Pageof 58